Text Size: A A A

Diabetic Macular Edema

The Regeneron VISTA trial for Diabetic Macular Edema

Why is this study being done? Diabetic macular edema (DME) occurs when blood vessels in the retina (light sensitive tissue in the back of the eye) are  Read Full Study >>


Geographic Atrophy

Acucela study (ACU-4429) for Geographic Atrophy

***THIS STUDY IS NO LONGER RECRUITING PATIENTS*** Why is this research study being done? This study is for an advanced form of macular degeneration c  Read Full Study >>

GSK infusion study for geographic atrophy

Why is this study being done? This study is for an advanced form of macular degeneration called geographic atrophy causes central vision loss with the  Read Full Study >>


Non-arteritic Ischemic Optic Neuropathy (NAION)

Covance after market study for patients with NAION

Protocol Name: 12912 Title: Prospective Case Crossover Study to Assess Whether PDE5 Inhibitor Exposure in Men With Erectile Dysfunction Increases the   Read Full Study >>

Quark intravitreal injection (QPI-1007) study for NAION

The purpose of this clinical trial is to test an investigational drug called "QPI-1007". It is being developed for vision loss that can occur  Read Full Study >>


Retinal Vein Occlusion

The Allergan 208397-001 trial for Branch and Central Retinal Vein Occlusions

Why is this study being done? The retina is the light-sensitive tissue at the back of your eye. The macula is a tiny oval area located at the center   Read Full Study >>


Uveitis

Abbott M10-877, M10-880 sub-cutaneous injections for non-infectious Uveitis

The VISUAL Clinical Trials for Uveitis Dr. Pravin Dugel at Retinal Consultants of AZ in Phoenix is recruiting patients in two uveitis clinical trials,  Read Full Study >>

The Lux LX-211-11 Uveitis Study

Why is this study being done? This study is for patients diagnosed with uveitis, or inflammation in the eye. Researchers want to find out if an invest  Read Full Study >>

The Santen SAKURA Trial

Why is this study being done? In this clinical research trial, the Sponsor of the study, Santen, Inc., is investigating 3 different doses of a drug ca  Read Full Study >>


Wet Macular Degeneration

Genzyme gene therapy study for wet Macular Degeneration

Protocol Name: sFLT01-AMD-00106 Title: A Phase 1, Open-Label, Multi-Center, Dose-Escalating, Safety and Tolerability Study of a Single Intravitreal In  Read Full Study >>

Ophthotech protocol OPH1001 for wet age-related macular degeneration

***THIS STUDY IS NO LONGER RECRUITING PATIENTS*** What is the purpose of this study? Ophthotech Corporation is studying an investigational drug, &ldq  Read Full Study >>

The Alcon SEE trial

Why is this study being done? This research study is for patients diagnosed with Wet Age –Related Macular Degeneration (wet AMD). Wet AMD is a d  Read Full Study >>

The Allergan REACH trial

Why is this study being done? The REACH study, sponsored by Allergan, is a trial of an investigational medication (AGN-150998) for wet age-related mac  Read Full Study >>